NIH-funded research R01 grant

Investigating how protein interactions at brain synapses relate to schizophrenia

Official title: Pathophysiologic roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia

Funded at Thomas Jefferson University · NIH-11040720 · Data updated 2026-11-12

This study is looking at how certain proteins in the brain might be linked to schizophrenia, with the hope that understanding these connections can help find new ways to treat the condition for people living with it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startDecember 1, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$706,404
NIH project number1R01MH138995-01
Project IDNIH-11040720 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia or those with a family history of the disorder.

Less likely to help

Patients without a diagnosis of schizophrenia or related disorders are unlikely to benefit from this research.

What this research studies

This research explores the genetic and molecular mechanisms behind schizophrenia, focusing on how certain protein interactions at synapses in the brain may contribute to the disorder. By examining the role of NMDA receptors and their associated proteins, the study aims to uncover how genetic variants lead to synaptic dysfunction in individuals with schizophrenia. Patients may benefit from insights gained into the biological processes that underlie their condition, potentially leading to new therapeutic targets. The research employs advanced genetic and molecular techniques to analyze these interactions and their effects on brain function.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that target the underlying biological mechanisms of schizophrenia.

How similar studies have gone: Previous research has shown promising results in understanding synaptic dysfunction in schizophrenia, indicating that this approach may yield valuable insights.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hahn, Chang-Gyu — Thomas Jefferson University
  • Study coordinator: Hahn, Chang-Gyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.